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Human lung fibroblasts may modulate
dendritic cell phenotype and function:
results from a pilot in vitro study
Olivia Freynet1,2,3,4†, Joëlle Marchal-Sommé1,2,3†, Francette Jean-Louis5, Arnaud Mailleux1,2,3, Bruno Crestani1,2,3,4,6*,
Paul Soler1,2,3 and Laurence Michel5,7*
Abstract
In human lung fibrotic lesions, fibroblasts were shown to be closely associated with immature dendritic cell (DC)
accumulation. The aim of the present pilot study was to characterize the role of pulmonary fibroblasts on DC phenotype
and function, using co-culture of lung fibroblasts from patients with idiopathic pulmonary fibrosis (IPF) and from control
patients, with a DC cell line MUTZ-3. We observed that co-culture of lung control and IPF fibroblasts with DCs reduced
the expression of specific DC markers and down-regulated their T-cell stimulatory activity. This suggests that
pulmonary fibroblasts might sustain chronic inflammation in the fibrotic lung by maintaining in situ a pool
of immature DCs.
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Findings
Background
We previously reported that in human fibrotic intersti-
tial lung disease, immature DC accumulate in large
numbers in areas of established fibrosis, in the close
vicinity of fibroblasts expressing the main chemokines
involved in the recruitment of immune cells [1–3].
Accumulating evidence indicates that the stromal micro-
environment plays an important role in the regulation of
the trafficking and phenotype and function regulation of
immune cells, including DC [4, 5].
Fibroblasts and other stromal cells from various tissues
have been shown to modulate DC differentiation and
activation [6–8] and may induce the development/differen-
tiation of DCs from blood monocytes or CD34+
hematopoietic precursors [9, 10]. Kitamura et al [11]
reported that fibroblasts have a crucial role in regulating
both fibrotic and immune responses in the lung by chemo-
kine secretion, favoring dendritic cell trafficking, through
TGF-β αvβ8-mediated activation. Dermal fibroblasts were
also reported to act as potent immunoregulatory cells able
to modulate the maturation of DCs [12–14].
Herein, we aimed to characterize in vitro the influence
of pulmonary fibroblasts on DC phenotype and function,
using co-culture of human pulmonary fibroblasts obtained
from patients with idiopathic pulmonary fibrosis (IPF) and
from control patients, with immature DCs developed
from the precursor cell line MUTZ-3 [15].
Materials
Primary fibroblasts
Primary fibroblasts were derived in Dulbecco’s modified
Eagle’s medium (DMEM, Life Technologies-Invitrogen,
Courtaboeuf, France) supplemented with 10 % FCS (Life
Technologies-Invitrogen) from lung tissue biopsies ob-
tained from 6 patients with IPF (age = 65.4 ± 10.6, 2 F),
and from 6 patients with removal of a primary lung
tumor without any fibrosis (control patients, age = 53 ±
14, 3 F), according to previous detailed procedures [16].
Fibroblasts were used at passage 5. No significant mor-
phological and phenotypic differences were observed
between IPF and control fibroblasts. Informed consent
was obtained before lung sampling. The protocol was
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MUTZ-3 dendritic cells
The CD34+ human MUTZ-3 progenitor cell line (ob-
tained from DSMZ, Braunschweig, Germany) maintained
in α-MEM (Life Technologies) supplemented with 20 %
FCS and 0.25 ng/ml rhGM-CSF (Gentaur, Bruxelles,
Belgium) express CD34 for 80 % and HLA-DR+ for 70 %,
as previously reported [17]. Generation of dendritic-like
cells MUTZ-3 DCs was obtained by culturing MUTZ-3
progenitor (4×105cells/ml) for 7 days in α-MEM with
20 % FCS, 10 ng/ml rhGM-CSF, 10 ng/ml rhIL-4
(Gentaur), and 0.5 ng/ml TNF-α (R&D Systems Europe,
Lille, France) (MUTZ − 3 DC medium) [17].
Co-cultures
MUTZ-3 DCs (1×106) were co-cultured with fibroblast
monolayers (80–90 % confluence) for 48 h in MUTZ-
3 DC medium either in 6-well tissue culture plates for
direct contact or in Transwell® support. As controls,
MUTZ-3 DCs and fibroblasts alone were cultured for
48 h under the same conditions.
Mixed Leukocyte Reaction
For mixed leukocyte reaction (MLR), human peripheral
blood mononuclear cells were isolated from one
leucocyte-enriched buffycoat, obtained from Etablisse-
ment Français du Sang (Paris, France), by Lymphocyte
Separation MediumM (GE Healthcare, PAA, Austria)
density gradient centrifugation, cultured in RPMI 1640
(Gibco, Life Technologies) with 10 % heat inactivated
human AB serum (RPMI complete medium) for 2 h in
order to eliminate adherent mononuclear cells and re-
suspended at 1×106 cells/ml RPMI complete medium.
MUTZ-3 DCs cultured alone or in the presence of fibro-
blasts as indicated above were collected, washed once
and resuspended in RPMI complete medium also. 2×104
DC were cultured with 1×105 allogeneic T cells in 96-
well round-bottom plates, in a final volume of 200 μl for
each well. All determinations were performed in sixpli-
cate. Cell proliferation was assessed for 6 days, with
during the last 18 h of the culture period, addition of
1 μCi of 3H-thymidine (Perkin-Elmer Wallac, Courtabeuf,
France) to each well. The cells were then harvested onto
FilterMat filters (Wallac) by using the Harvester 96 cell
Tomtec harvester, and incorporated radioactivity was
determined using a MicroBeta plate reader (Wallac
Trilux 1450 MicroBeta Liquid Scintillation Counter &
Luminometer, WS-Trilux 1450).
Flow Cytometry
Cell surface staining was performed in phosphate-buffered
saline (PBS, Life Technologies) (without calcium and
magnesium) containing 1 % bovine serum albumin (BSA)
(Sigma-Aldrich) using fluorochrome-conjugated monoclo-
nal antibodies recognizing MHC class II and DC-specific
molecules: HLA-DR-PE (Pharmingen-BD, L’Isle d’Abeau,
France), CD1a-PE, CD34-FITC, CD83-PE, CD86-PE, and
CD209-PE (Immunotech-Beckman Coulter, Marseille,
France) for 20 min at 4 °C. After two washes in PBS/BSA,
the cells were fixed in formaldehyde 1 % and subsequently
analyzed using an Epics cytometer (Beckman Coulter).
Appropriate gating was used to exclude cell debris. Gating
on isotype control staining was used to identify the per-
centage of cells expressing DC-specific markers. Data
were analyzed with FlowJo software (Tree Star, Inc., San
Carlos, CA). Analysis of each epitope staining was
assessed using both the percentage of positive cells (%)
and the mean fluorescence intensity (MFI) of DCs.
Cytokine Production
Supernatants from MUTZ-3 DC and fibroblasts either cul-
tured alone or in co-culture were centrifuged (1600 rpm,
10 min, 4 °C) and frozen at −70 °C until assayed using spe-
cific enzyme-linked immunosorbent assays (ELISAs) from
R&D Systems (Quantikine, R&D Systems, Abingdon, UK).
Statistical analysis
Data are presented as means (± SEM), or as individual
values and median. Comparisons were performed with
Wilcoxon paired nonparametric test for group compari-
sons or Mann–Whitney U test. P values < 0.05 were
considered significant. Statistical analysis was performed
with Prism 5 (Graphpad Software Inc., La Jolla, CA USA).
Results
MUTZ-3 DCs obtained after a 7 day-differentiation
culture (n = 12) were characterized by a low CD34
expression (<15 %), and the expression of CD209 (33.7 ±
1.6 %, mean ± SD) (marker of immaturity), HLA-DR
(66.7 ± 2.8 %) and CD86 (59.5 ± 1 %). Few cells, if any,
expressed the maturation marker CD83 (0.68 ± 0.23 %).
These immature cells can undergo significant matur-
ation by stimulation with 25 ng/ml TNF-α during 48 h
as detected by an increased expression of HLA-DR
(88.6 ± 1.3 % p ≤ 0.001) and the induction of the matur-
ation marker CD83 (47.2 ± 2.1 %).
Co-culture of lung fibroblasts with immature MUTZ3-
DCs for 48 h induced a 20 % decrease of HLA-DR expres-
sion and a 40 % decrease in CD83 and CD86 expression
by DCs (Fig. 1). CD209 expression by DC was not signifi-
cantly altered by co-culture (data not shown). It is note-
worthy that IPF and control fibroblasts had a similar
inhibitory effect on DCs.
In accordance with the decreased expression of activa-
tion/maturation markers, co-culture of lung fibroblasts
from either control or IPF patients and MUTZ-3 DCs
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induced a significant 30 % reduction of lymphocyte
allostimulatory activity as compared to that observed for
MUTZ-3 DCs cultured alone (Table 1).
Lung fibroblasts might alter MUTZ-3 DC phenotype by
either direct cell-cell contact or soluble factors. Of interest,
MUTZ-3 DCs co-cultured with fibroblasts using modified
Boyden chambers (Transwell® support) to prevent direct
cell-cell contact did also show significant decrease in DC
CD86 and CD83 markers (Fig. 1b lower panels), decreases
that were not significantly different from those ob-
served in cell-cell contact conditions (upper panels).
Numerous cytokines such as IL-6, G-CSF, M-CSF,
VEGF, and TGF-β [18, 19] are produced by fibroblasts
in the microenvironment and may inhibit MUTZ-3 DC
maturation and function. Accordingly, we detected
measurable levels of these cytokines in the culture
supernatants of control and IPF fibroblasts, either alone
or in co-culture (Fig. 2). Although IL6 production was
lower in control fibroblasts alone compared to IPF ones,
no differences were observed between the two fibroblast
types when co-cultured with MUTZ3-DC, either in con-
tact or not. Noteworthy, a significant decrease in MCSF
production was detected for both populations when
cultured in contact with MUTZ-3 cells.
Discussion
The present study demonstrates that lung fibroblasts
co-cultured with DCs, differentiated from CD34+
MUTZ-3 precursors and closely resembling monocyte-
derived DCs in terms of morphology, phenotype and
function [15, 17, 20–22], induced a reduced MHC
classII, CD86, and CD83 expression by DCs, with a
decrease in their T-cell stimulatory activity. These
findings support the notion that lung fibroblasts are
effective in maintaining DCs in an immature state
within fibrotic lesions. Our results are in line with re-
cent data showing that human dermal fibroblasts are
potent immunoregulatory cells inhibiting allogeneic T-
cell activation by DCs [11]. Moreover, dermal fibro-
blasts inhibited T-cell proliferation in response to
DCs with similar potency to bone marrow-derived
mesenchymal stem cells (MSC), suggesting that im-
munosuppression is a general property of stromal
cells [11, 23].
The absence of difference between IPF and control
fibroblasts in our study suggests that the inhibitory effect
of lung fibroblasts on DC differentiation and function is
an intrinsic property of this cell type, independently of the
physiological context. This possibility, which fits well with
the recently documented immunoregulatory function of
(See figure on previous page.)
Fig. 1 Phenotype of MUTZ-3 DCs alone or cultured with control or IPF fibroblasts for 48 h. Immature MUTZ-3 DCs (1×106) were directly added
to fibroblasts monolayers grown to confluence in 6-well tissue culture plates (direct contact) or fibroblasts (low compartment) and MUTZ-3 DCs
(high compartment) were separated using modified Boyden chambers (Transwell® permeable support-0.4 μm) to prevent direct cell-cell contact,
for 48 h in MUTZ-3 DC medium (Transwell condition). Controls were MUTZ-3 DCs cultured alone for 48 h in the same condition. Flow Cytometry
analysis was assessed on DCs stained with monoclonal antibodies HLA-DR-PE (Pharmingen-BD), CD34-FITC, CD83-PE, CD86-PE, and CD209-PE
(Immunotech-Beckman Coulter), and acquired with an Epics cytometer (Beckman Coulter). a One representative experiment or (b) percentage of
positive cells for HLA-DR, CD86, and CD83 expression, represented as mean (dark horizontal bars) and individual values (n = 10) for direct contact
co-cultures (upper panels) and Transwell® co-cultures (lower panels). MFI: Mean fluorescence intensity. **p < 0.01, ***p < 0.001. Statistical comparisons
were performed with Wilcoxon paired nonparametric test for group comparisons or Kruskal-Wallis for unpaired nonparametric test, using
Prism 5 (Graphpad Software Inc.)
Table 1 Mixed leukocyte reaction (MLR)
Conditions MUTZ-3 DC medium Contact Co-culture
medium Control Fibro IPF Fibro
Lymphocyte Proliferation (mean cpm± SD, n = 3) 56,870 ± 6110 40,236 ± 6047 34,322 ± 2843
p value (versus MUTZ-3 DC) 0.02 0.01
Conditions MUTZ-3 DC medium Transwell Co-culture
medium Control Fibro IPF Fibro
Lymphocyte Proliferation (mean cpm± SD, n = 3) 36,967 ± 4942 29,328 ± 3215 26,890 ± 6564
p value (versus MUTZ-3 DC) 0.04 0.05
MLR was performed by culturing with 100 000 lymphocytes (depleted of adherent mononuclear cells by a 2 h-lasting culture) and 20 000 MUTZ-3 DCs previously
cultured alone (medium) or co-cultured with control or IPF fibroblasts for 48 h (as in Fig. 1) in 200 μl RPMI complete medium (n = 6 for each condition) for 6 days
During the last 18 h, 1 μCi of 3H-thymidine (Perkin-Elmer Wallac) was added per well. Incorporated radioactivity was determined using a MicroBeta plate reader
(Wallac WS-Trilux 1450
Results are presented as mean (±SD) lymphocyte proliferation induced by MUTZ-3 DCs previously alone (medium) or co-cultured with control or IPF fibroblasts
either in direct contact or in transwell conditions during 48 h before MLR
3H-thymidine incorporation of 105 lymphocytes alone was 605 ± 436 cpm and 3H-thymidine incorporation of 20 000 MUTZ3 DC alone was 138 ± 59 cpm,
(mean ± SD, n = 6)
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MSC [24], needs to be further assessed with fibroblasts
isolated from various other tissues.
Conclusion
In conclusion, our findings suggest that lung fibroblasts
by their ability to modulate DC differentiation and func-
tion, are able to participate in pulmonary inflammatory
and immune responses. Whereas their role in produc-
tion of extracellular matrix proteins is a key factor in
healing and remodeling, their likely interaction with lung
DCs might be also considered as critical in inflammatory
lung disorders.
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